1 |
Mahant N, Clouston PD, Lorentz IT. The current use of botulinum toxin. J Clin Neurosci 2000; 7: 389-94.
DOI
ScienceOn
|
2 |
Aoki KR. Evidence for antinociceptive activity of botulinum toxin type A in pain management. Headache 2003; 43(Suppl 1): 9-15.
DOI
ScienceOn
|
3 |
Park HJ, Lee Y, Lee J, Park C, Moon DE. The effects of botulinum toxin A on mechanical and cold allodynia in a rat model of neuropathic pain. Can J Anaesth 2006; 53: 470-7.
DOI
ScienceOn
|
4 |
Swift A. The current uses of botulinum toxin. Hosp Med 2003; 64: 450-1.
DOI
|
5 |
Radensky PW, Archer JW, Dournaux SF, O'Brien CF. The estimated cost of managing focal spasticity: a physician practice patterns survey. Neurorehabil Neural Repair 2001; 15: 57-68.
DOI
ScienceOn
|
6 |
Mailis A, Furlan A. Sympathectomy for neuropathic pain. Cochrane Database Syst Rev 2003; 2: CD002918.
|
7 |
Ranoux D, Attal N, Morain F, Bouhassira D. Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain. Ann Neurol 2008; 64: 274-83.
DOI
ScienceOn
|
8 |
Arezzo JC. Possible mechanisms for the effects of botulinum toxin on pain. Clin J Pain 2002; 18(6 Suppl): 125-32.
DOI
|
9 |
Bach-Rojecky L, Lackovic Z. Central origin of the antinociceptive action of botulinum toxin type A. Pharmacol Biochem Behav 2009; 94: 234-8.
DOI
ScienceOn
|
10 |
Kim HJ, Seo K, Yum KW, Oh YS, Yoon TG, Yoon SM. Effects of botulinum toxin type A on the superior cervical ganglia in rabbits. Auton Neurosci 2002; 102: 8-12.
DOI
ScienceOn
|
11 |
Ailani J, Young WB. The role of nerve blocks and botulinum toxin injections in the management of cluster headaches. Curr Pain Headache Rep 2009; 13: 164-7.
DOI
ScienceOn
|
12 |
Carroll I, Clark JD, Mackey S. Sympathetic block with botulinum toxin to treat complex regional pain syndrome. Ann Neurol 2009; 65: 348-51.
DOI
ScienceOn
|
13 |
Lee HK, Yang SK, Lee HJ, Lee SY, Kim SM, Kim BS, et al. The effect of ganglion impar block for excessive perianal sweating. Korean J Pain 1995; 8: 363-6.
|
14 |
Jin L, Kollewe K, Krampfl K, Dengler R, Mohammadi B. Treatment of phantom limb pain with botulinum toxin type A. Pain Med 2009; 10: 300-3.
DOI
ScienceOn
|
15 |
Welch MJ, Purkiss JR, Foster KA. Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins. Toxicon 2000; 38: 245-58.
DOI
ScienceOn
|
16 |
Cui M, Khanijou S, Rubino J, Aoki KR. Subcutaneous administration of botulinum toxin A reduces formalin-induced pain. Pain 2004; 107: 125-33.
DOI
ScienceOn
|
17 |
Tait RC, Chibnall JT, Krause S. The pain disability index: psychometric properties. Pain 1990; 40: 171-82.
DOI
ScienceOn
|
18 |
Toshniwal GR, Dureja GP, Prashanth SM. Transsacrococcygeal approach to ganglion impar block for management of chronic perineal pain: a prospective observational study. Pain Physician 2007; 10: 661-6.
|
19 |
Reig E, Abejon D, del Pozo C, Insausti J, Contreras R. Thermocoagulation of the ganglion impar or ganglion of Walther: description of a modified approach. Preliminary results in chronic, nononcological pain. Pain Pract 2005; 5: 103-10.
DOI
ScienceOn
|
20 |
Kim SK, Ahn CS, Cho YR, Lim SY, Shin KM, Hong SY, et al. Ganglion impar block in the management of rectal tenesmoid pain. Korean J Pain 1996; 9: 226-8.
|